- call +1-201-465-4211
- email sales@mrinsights.biz
A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
Scope of the Report:
This report focuses on the Drug-Eluting Stents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.
The worldwide market for Drug-Eluting Stents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rapamycin
Paclitaxel
Everolimus
Others
Market Segment by Applications, can be divided into
Angina Pectoris
Myocardial Infarction
There are 15 Chapters to deeply display the global Drug-Eluting Stents market.
Chapter 1, to describe Drug-Eluting Stents Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drug-Eluting Stents, with sales, revenue, and price of Drug-Eluting Stents, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug-Eluting Stents, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drug-Eluting Stents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drug-Eluting Stents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Drug-Eluting Stents Introduction
1.2 Market Analysis by Type
1.2.1 Rapamycin
1.2.2 Paclitaxel
1.2.3 Everolimus
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Angina Pectoris
1.3.2 Myocardial Infarction
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Business Overview
2.1.2 Drug-Eluting Stents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic, Inc.
2.2.1 Business Overview
2.2.2 Drug-Eluting Stents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Drug-Eluting Stents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Lepu Medical
2.4.1 Business Overview
2.4.2 Drug-Eluting Stents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Lepu Medical Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 MicroPort Scientific Corporation
2.5.1 Business Overview
2.5.2 Drug-Eluting Stents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cook Medical
2.6.1 Business Overview
2.6.2 Drug-Eluting Stents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cook Medical Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Terumo
2.7.1 Business Overview
2.7.2 Drug-Eluting Stents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Terumo Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biosensors International
2.8.1 Business Overview
2.8.2 Drug-Eluting Stents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biosensors International Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Balton
2.9.1 Business Overview
2.9.2 Drug-Eluting Stents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Balton Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AlviMedica Medical Technologies
2.10.1 Business Overview
2.10.2 Drug-Eluting Stents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biotronik
2.11.1 Business Overview
2.11.2 Drug-Eluting Stents Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biotronik Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Shandong JW Medical
2.12.1 Business Overview
2.12.2 Drug-Eluting Stents Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Shandong JW Medical Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sino Medical
2.13.1 Business Overview
2.13.2 Drug-Eluting Stents Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sino Medical Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Beijing AMSINO
2.14.1 Business Overview
2.14.2 Drug-Eluting Stents Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Beijing AMSINO Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
2.15.1 Business Overview
2.15.2 Drug-Eluting Stents Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC) Drug-Eluting Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drug-Eluting Stents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Drug-Eluting Stents Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drug-Eluting Stents Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Drug-Eluting Stents Manufacturer Market Share in 2017
3.3.2 Top 6 Drug-Eluting Stents Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Drug-Eluting Stents Market Analysis by Regions
4.1 Global Drug-Eluting Stents Sales, Revenue and Market Share by Regions
4.1.1 Global Drug-Eluting Stents Sales and Market Share by Regions (2013-2018)
4.1.2 Global Drug-Eluting Stents Revenue and Market Share by Regions (2013-2018)
4.2 North America Drug-Eluting Stents Sales and Growth Rate (2013-2018)
4.3 Europe Drug-Eluting Stents Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Drug-Eluting Stents Sales and Growth Rate (2013-2018)
4.5 South America Drug-Eluting Stents Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Drug-Eluting Stents Sales and Growth Rate (2013-2018)
5 North America Drug-Eluting Stents by Countries
5.1 North America Drug-Eluting Stents Sales, Revenue and Market Share by Countries
5.1.1 North America Drug-Eluting Stents Sales and Market Share by Countries (2013-2018)
5.1.2 North America Drug-Eluting Stents Revenue and Market Share by Countries (2013-2018)
5.2 United States Drug-Eluting Stents Sales and Growth Rate (2013-2018)
5.3 Canada Drug-Eluting Stents Sales and Growth Rate (2013-2018)
5.4 Mexico Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6 Europe Drug-Eluting Stents by Countries
6.1 Europe Drug-Eluting Stents Sales, Revenue and Market Share by Countries
6.1.1 Europe Drug-Eluting Stents Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Drug-Eluting Stents Revenue and Market Share by Countries (2013-2018)
6.2 Germany Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6.3 UK Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6.4 France Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6.5 Russia Drug-Eluting Stents Sales and Growth Rate (2013-2018)
6.6 Italy Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7 Asia-Pacific Drug-Eluting Stents by Countries
7.1 Asia-Pacific Drug-Eluting Stents Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drug-Eluting Stents Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Drug-Eluting Stents Revenue and Market Share by Countries (2013-2018)
7.2 China Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7.3 Japan Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7.4 Korea Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7.5 India Drug-Eluting Stents Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Drug-Eluting Stents Sales and Growth Rate (2013-2018)
8 South America Drug-Eluting Stents by Countries
8.1 South America Drug-Eluting Stents Sales, Revenue and Market Share by Countries
8.1.1 South America Drug-Eluting Stents Sales and Market Share by Countries (2013-2018)
8.1.2 South America Drug-Eluting Stents Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Drug-Eluting Stents Sales and Growth Rate (2013-2018)
8.3 Argentina Drug-Eluting Stents Sales and Growth Rate (2013-2018)
8.4 Colombia Drug-Eluting Stents Sales and Growth Rate (2013-2018)
9 Middle East and Africa Drug-Eluting Stents by Countries
9.1 Middle East and Africa Drug-Eluting Stents Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drug-Eluting Stents Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Drug-Eluting Stents Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Drug-Eluting Stents Sales and Growth Rate (2013-2018)
9.3 UAE Drug-Eluting Stents Sales and Growth Rate (2013-2018)
9.4 Egypt Drug-Eluting Stents Sales and Growth Rate (2013-2018)
9.5 Nigeria Drug-Eluting Stents Sales and Growth Rate (2013-2018)
9.6 South Africa Drug-Eluting Stents Sales and Growth Rate (2013-2018)
10 Global Drug-Eluting Stents Market Segment by Type
10.1 Global Drug-Eluting Stents Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drug-Eluting Stents Sales and Market Share by Type (2013-2018)
10.1.2 Global Drug-Eluting Stents Revenue and Market Share by Type (2013-2018)
10.2 Rapamycin Sales Growth and Price
10.2.1 Global Rapamycin Sales Growth (2013-2018)
10.2.2 Global Rapamycin Price (2013-2018)
10.3 Paclitaxel Sales Growth and Price
10.3.1 Global Paclitaxel Sales Growth (2013-2018)
10.3.2 Global Paclitaxel Price (2013-2018)
10.4 Everolimus Sales Growth and Price
10.4.1 Global Everolimus Sales Growth (2013-2018)
10.4.2 Global Everolimus Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Drug-Eluting Stents Market Segment by Application
11.1 Global Drug-Eluting Stents Sales Market Share by Application (2013-2018)
11.2 Angina Pectoris Sales Growth (2013-2018)
11.3 Myocardial Infarction Sales Growth (2013-2018)
12 Drug-Eluting Stents Market Forecast (2018-2023)
12.1 Global Drug-Eluting Stents Sales, Revenue and Growth Rate (2018-2023)
12.2 Drug-Eluting Stents Market Forecast by Regions (2018-2023)
12.2.1 North America Drug-Eluting Stents Market Forecast (2018-2023)
12.2.2 Europe Drug-Eluting Stents Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drug-Eluting Stents Market Forecast (2018-2023)
12.2.4 South America Drug-Eluting Stents Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drug-Eluting Stents Market Forecast (2018-2023)
12.3 Drug-Eluting Stents Market Forecast by Type (2018-2023)
12.3.1 Global Drug-Eluting Stents Sales Forecast by Type (2018-2023)
12.3.2 Global Drug-Eluting Stents Market Share Forecast by Type (2018-2023)
12.4 Drug-Eluting Stents Market Forecast by Application (2018-2023)
12.4.1 Global Drug-Eluting Stents Sales Forecast by Application (2018-2023)
12.4.2 Global Drug-Eluting Stents Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Drug-Eluting Stents Picture
Table Product Specifications of Drug-Eluting Stents
Figure Global Sales Market Share of Drug-Eluting Stents by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
